QGEN — QIAGEN NV
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying QGEN?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 1 tracked investors who changed their QGEN position last quarter, 0 bought and 1 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Contraction regime).
- +3 tracked investors reported holding QGEN at their latest filing
- +Macro Health is 55/100 in a Contraction regime — historically acceptable for this sectorsource
- −1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/17/2026.
About QIAGEN NV (QGEN)
QIAGEN NV (QGEN) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $158M. Across recent filings, tracked investors recorded 3 new positions, 0 increased, 0 reduced, and 3 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in QGEN
How many top investors track QGEN
A small number of top investors own this.
QGEN Ownership Composition
How QIAGEN NV is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting QGEN
2 tracked investors have since exited this position — listed separately below.
- Izzy EnglanderJun 30, 2026Millennium ManagementShares4.1MValue$158.4M% Portfolio0.06%
- Ken GriffinJun 30, 2026Citadel AdvisorsShares866.7KValue$33.9M% Portfolio0.00%
- Steve CohenJun 30, 2026Point72 Asset ManagementShares1.6MValue$62.1M% Portfolio0.07%
Previously held QGEN
These investors reported QGEN in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Ray Dalio | Bridgewater Associates | 5.8K | $259.4K | Dec 31, 2024 |
| Paul Tudor Jones | Tudor Investment Corp | 12.5K | $602.4K | Jun 30, 2025 |
Recent activity
- Sold$0(-100.00%)Feb 14, 2024
- New$259.4KFeb 13, 2025
- Sold$0(-100.00%)May 14, 2025
- New$2.1MNov 14, 2024
- Sold$0(-100.00%)Feb 14, 2025
- New$3.3MNov 13, 2023
Frequently asked questions
- How many institutional investors hold QGEN?
- 3 tracked institutional investors disclosed a position in QGEN (QIAGEN NV) in their most recent 13F filing.
- Who is the largest institutional holder of QGEN?
- Izzy Englander, Millennium Management, holds the largest disclosed position in QGEN, valued at $158M.
- Did institutional ownership of QGEN increase or decrease?
- Across recent 13F filings, tracked investors recorded 3 new positions, 0 increased, 0 reduced, and 3 fully exited QGEN.
- Where does this QGEN ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.